BINEX Co., Ltd. (KOSDAQ:053030)
12,570
+170 (1.37%)
At close: Mar 20, 2026
BINEX Market Cap
BINEX has a market cap or net worth of 400.33 billion as of March 20, 2026. Its market cap has decreased by -30.55% in one year.
Market Cap
400.33B
Enterprise Value
478.00B
Revenue
168.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,570.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 400.33B, an increase of 1,483.19%. That is a compound annual growth rate of 12.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 400.33B | -16.09% |
| Dec 30, 2025 | 477.08B | -18.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Cross Holdings | 639.71B |
| Genomictree | 488.97B |
| SillaJen | 473.79B |
| Anterogen.Co.,Ltd. | 439.27B |
| GC Cell | 398.97B |
| Bioneer | 313.34B |
| JETEMA, | 311.00B |
| HLB Therapeutics | 275.93B |